Medical-focused artificial intelligence startup OpenEvidence has reportedly considered raising $200 million at a $20 billion valuation.However, the company is unlikely to proceed, partly because the fundraise will dilute founders and shareholders, The Information reported Friday (July…
Back to News
AI
Medical AI Startup OpenEvidence Weighs $200 Million Funding Round
Biztoc.com·July 20, 2026
AI Summary
Medical AI startup OpenEvidence is considering a $200 million funding round that would value the company at $20 billion. The company is unlikely to move forward with the raise due to concerns about dilution to existing founders and shareholders.
Full story reconstructed from Biztoc.com. Formatting and media may differ from the original.
View original at Biztoc.comWas this useful?